... the U.S. It's also planning to begin two phase 1/2a clinical studies of experimental gene therapy OCU400 in treating genetic eye diseases this year.
https://www.google.com/url?rct=j&sa=t&url=https://www.fool.com/investing/2021/02/16/why-ocugen-stock-is-jumping-today/&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNGirqT1iYp4Njzo-nYYdDSmdYAT5w
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.